Pearls & Oy-sters: Adolescent-onset adrenomyeloneuropathy and arrested cerebral adrenoleukodystrophy.
作者信息
Lin Jieru E, Armour Eric A, Heshmati Arezou, Umandap Christine, Couto Julia J, Iglesias Alejandro D, Mallack Eric J, Bain Jennifer M
机构信息
From the Department of Medicine (J.E.L.), University of Illinois at Chicago; Division of Child Neurology, Department of Neurology (J.E.L., E.A.A., A.H., J.M.B.), Division of Medical Genetics, Department of Pediatrics (C.U., A.D.I.), and Department of Anesthesia (J.C.), Columbia University College of Physicians and Surgeons; The Columbia University Irving Medical Center (J.E.L, E.A.A, A.H, J.M.B, C.U., A.D.I, J.J.C); and Division of Child Neurology (E.J.M.), Department of Pediatrics, Weill Cornell Medicine, New York-Presbyterian Hospital, New York.
出版信息
Neurology. 2019 Jul 9;93(2):81-84. doi: 10.1212/WNL.0000000000007755.
Abstract
摘要
相似文献
1
Pearls & Oy-sters: Adolescent-onset adrenomyeloneuropathy and arrested cerebral adrenoleukodystrophy.
Neurology. 2019 Jul 9;93(2):81-84. doi: 10.1212/WNL.0000000000007755.
2
A novel ABCD1 gene mutation causes adrenomyeloneuropathy in a Chinese family.
Brain Behav. 2019 Oct;9(10):e01416. doi: 10.1002/brb3.1416. Epub 2019 Sep 26.
3
A novel missense mutation in the ABCD1 gene of a Chinese boy diagnosed with X-linked adrenoleukodystrophy: case report.
Neurol Sci. 2019 May;40(5):1093-1096. doi: 10.1007/s10072-018-3596-7. Epub 2018 Oct 20.
4
Rare variability in adrenoleukodystrophy: a case report.
J Med Case Rep. 2018 Jun 28;12(1):182. doi: 10.1186/s13256-018-1722-z.
5
Progressive hemiparesis reveals X-linked adrenoleukodystrophy in a 3.5-year-old boy.
Acta Neurol Belg. 2021 Feb;121(1):261-263. doi: 10.1007/s13760-020-01306-5. Epub 2020 Feb 27.
6
Clinical reasoning: a 56-year-old man with progressive spasticity.
Neurology. 2013 Feb 26;80(9):e84-8. doi: 10.1212/WNL.0b013e3182840729.
7
Unusual early-onset and severe adrenomyeloneuropathy in women.
Eur J Neurol. 2020 Nov;27(11):e73. doi: 10.1111/ene.14297. Epub 2020 Jun 4.
8
Primary adrenal insufficiency due to X-linked adrenoleukodystrophy diagnosed in adulthood.
Endocrinol Diabetes Nutr. 2017 Oct;64(8):458-459. doi: 10.1016/j.endinu.2017.07.001. Epub 2017 Aug 2.
9
A first case of adrenomyeloneuropathy with mutation Y174S of the adrenoleukodystrophy gene.
Neuro Endocrinol Lett. 2017 Feb;38(1):13-18.
10
Teaching NeuroImages: Frontal lobe involvement in adult-onset cerebral X-linked adrenoleukodystrophy.
Neurology. 2019 Sep 24;93(13):e1326-e1327. doi: 10.1212/WNL.0000000000008181.
引用本文的文献
1
A novel ABCD1 gene mutation causes adrenomyeloneuropathy presenting with spastic paraplegia: A case report.
Medicine (Baltimore). 2024 Apr 19;103(16):e37874. doi: 10.1097/MD.0000000000037874.
2
Adult-onset leukodystrophies: a practical guide, recent treatment updates, and future directions.
Front Neurol. 2023 Jul 26;14:1219324. doi: 10.3389/fneur.2023.1219324. eCollection 2023.
3
Typical and atypical phenotype and neuroimaging of X-linked adrenoleukodystrophy in a Chinese cohort.
Neurol Sci. 2022 May;43(5):3255-3263. doi: 10.1007/s10072-021-05859-y. Epub 2022 Jan 8.
4
A novel G1202A mutation in a Chinese patient with pure adrenomyeloneuropathy and literature review.
Genes Dis. 2020 Jan 28;8(5):709-714. doi: 10.1016/j.gendis.2020.01.009. eCollection 2021 Sep.
5
MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines.
J Inherit Metab Dis. 2021 May;44(3):728-739. doi: 10.1002/jimd.12356. Epub 2021 Jan 9.
6
Clinical and radiographic course of arrested cerebral adrenoleukodystrophy.
Neurology. 2020 Jun 16;94(24):e2499-e2507. doi: 10.1212/WNL.0000000000009626. Epub 2020 Jun 1.
7
The Landscape of Hematopoietic Stem Cell Transplant and Gene Therapy for X-Linked Adrenoleukodystrophy.
Curr Treat Options Neurol. 2019 Nov 25;21(12):61. doi: 10.1007/s11940-019-0605-y.
本文引用的文献
1
Adulthood leukodystrophies.
Nat Rev Neurol. 2018 Feb;14(2):94-105. doi: 10.1038/nrneurol.2017.175. Epub 2018 Jan 5.
2
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy.
N Engl J Med. 2017 Oct 26;377(17):1630-1638. doi: 10.1056/NEJMoa1700554. Epub 2017 Oct 4.
3
X-linked adrenoleukodystrophy: pathogenesis and treatment.
Curr Neurol Neurosci Rep. 2014 Oct;14(10):486. doi: 10.1007/s11910-014-0486-0.
4
Pathophysiology of X-linked adrenoleukodystrophy.
Biochimie. 2014 Mar;98(100):135-42. doi: 10.1016/j.biochi.2013.11.023. Epub 2013 Dec 4.
5
Hypoperfusion predicts lesion progression in cerebral X-linked adrenoleukodystrophy.
Brain. 2012 Sep;135(Pt 9):2676-83. doi: 10.1093/brain/aws206.
6
Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.
Blood. 2011 Aug 18;118(7):1971-8. doi: 10.1182/blood-2011-01-329235. Epub 2011 May 17.
7
Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study.
Lancet Neurol. 2007 Aug;6(8):687-92. doi: 10.1016/S1474-4422(07)70177-1.
8
Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy.
Arch Neurol. 2007 May;64(5):659-64. doi: 10.1001/archneur.64.5.659.
9
X-linked adrenoleukodystrophy.
Nat Clin Pract Neurol. 2007 Mar;3(3):140-51. doi: 10.1038/ncpneuro0421.
10
Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy.
Neurology. 2002 Mar 26;58(6):901-7. doi: 10.1212/wnl.58.6.901.
Zotero 插件